Natura &Co Holding completes corporate simplification in 2025

Natura &Co Holding S.A. held its Q4 2025 earnings call on March 17, 2026. CEO João Paulo Brotto Ferreira described 2025 as a watershed year, marked by the completion of a corporate simplification cycle started in 2022.

Natura &Co Holding S.A. (NTCOY), which now trades under the ticker NATU3 following a reverse merger, conducted its Q4 2025 earnings call on March 17, 2026, at 8:00 AM EDT. The call featured João Paulo Brotto Ferreira, CEO of Latin America and member of the executive board, and Silvia Lopes Vilas Magalhaes, CFO and IR officer. Analysts from firms including XP Investimentos, JPMorgan Chase, Itaú Corretora, Morgan Stanley, Citigroup, and Goldman Sachs participated via conference call. A slide deck was posted to the company's IR website beforehand. In his opening remarks, Ferreira stated: '2025 was a watershed year for the company as we finally wrapped up the corporate simplification cycle we kicked off back in 2022 and led by Fabio Barbosa.' He highlighted key achievements, including the divestiture of Avon International, Avon CARD, and Avon Russia over the past year. The company also streamlined its holding structure through the reverse merger, restoring trading under NATU3. Operationally, Natura &Co completed Wave 2 integration in Mexico and Argentina. Ferreira concluded: 'As a consequence, the company is back to basics, with a laser focus on our core Latin American operations.' The call emphasized a return to core operations after these restructuring efforts.

Verwandte Artikel

Nuvation Bio Inc. conducted its first quarter 2026 earnings call on May 4, 2026. The company reviewed financial results for the period ending March 31, 2026, and provided a business update. Executives including CEO David Hung participated in the discussion.

Von KI berichtet

Wacoal Holdings Corp released a slide deck for its 2026 Q4 earnings call on May 24. The materials were issued alongside the quarterly results discussion.

Ecopetrol wird am 12. und 13. Mai über seine Geschäftstätigkeit, Umsätze und das EBITDA für das erste Quartal 2026 berichten. Der Interimspräsident Juan Carlos Hurtado wird die Zahlen anstelle von Ricardo Roa präsentieren, der Urlaub sowie unbezahlte Freistellung beantragt hat. Das Unternehmen prognostiziert im Vergleich zum Vorjahr einen Rückgang bei Umsatz und Nettogewinn.

Von KI berichtet

Aytu BioPharma conducted its earnings call for the fiscal 2026 third quarter on May 13, 2026. Executives discussed operational and financial results for the period ended March 31, 2026.

Freitag, 15. Mai 2026, 12:35 Uhr

Koç Holding publishes Q1 2026 earnings presentation

Freitag, 15. Mai 2026, 02:19 Uhr

ARS Pharmaceuticals reports strong start to 2026 in earnings call

Donnerstag, 14. Mai 2026, 06:51 Uhr

Globant holds Q1 2026 earnings conference call

Montag, 11. Mai 2026, 15:23 Uhr

Ceva holds first quarter 2026 earnings conference call

Montag, 11. Mai 2026, 06:05 Uhr

CI&T Inc. holds Q1 2026 earnings call

Freitag, 01. Mai 2026, 15:49 Uhr

ArcelorMittal holds Q1 2026 earnings call

Mittwoch, 29. April 2026, 10:18 Uhr

Puig reports 4.7% revenue growth in Q1 2026

Sonntag, 26. April 2026, 03:46 Uhr

Unilever baut sich unter Fernández radikal um

Donnerstag, 19. März 2026, 15:11 Uhr

Samsonite Group S.A. publishes 2025 Q4 earnings call presentation

Donnerstag, 12. März 2026, 21:47 Uhr

Ulta Beauty publishes Q4 2025 earnings call presentation

 

 

 

Diese Website verwendet Cookies

Wir verwenden Cookies für Analysen, um unsere Website zu verbessern. Lesen Sie unsere Datenschutzrichtlinie für weitere Informationen.
Ablehnen